StockData
Kailera Therapeutics, Inc. logo

Kailera Therapeutics, Inc. (KLRA) stock

KLRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$12.20−0.37 (-2.94%)

Close on Nov 17, 2026Market cap $1.58BP/E –Yield –

Kailera Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

No profit margin figures for Kailera Therapeutics

Kailera Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Kailera Therapeutics figures

See a number that looks wrong?